Fig. 4
From: LncRNA-ANRIL regulates CDKN2A to promote malignant proliferation of Kasumi-1 cells
LncRNA-ANRIL upregulated CDKN2A expression. A. Downstream targets interacting with ANRIL were predicted using the RNAINTER database. B-F. RT-qPCR and Western blotting analyses quantify CDKN2A expression levels in Kasumi-1 cells and clinical peripheral blood samples. G. Predicted binding site map of ANRIL and CDKN2A. H. RIP assay verifies the direct interaction between ANRIL and CDKN2A in Kasumi-1 cells. *P < 0.05, **P < 0.01, ***P < 0.001